Cannabis Concentrates Okay for Patients: Arizona Supreme Court Rules
The Arizona medical cannabis community and business industry can finally exhale: The state’s Supreme Court decided a crucial appeal on 5/28/2019 by siding 7-0 with patients and state voters on cannabis resin extracts.
Parties in the case of State of Arizona v. Rodney Christopher Jones received word that morning that Jones had won his appeal.
“We hold that [Arizona Medical Marijuana Act’s] definition of marijuana includes both its dried-leaf/flower form and extracted resin, including hashish,” the court stated in its unanimous ruling.
The ruling means no change for the medical marijuana industry — vape-pen cartridges, concentrates like shatter and wax, infused food and drinks, patches, tinctures, and topicals will not be banned, as had been feared.
The question of whether the AMMA applies to resin extracts is finally settled. Tension over resin involving disputes between patients and law enforcement date back to 2010, when voters first approved the state’s cannabis program.
If the high court had ruled instead that the voter-approved 2010 Arizona Medical Marijuana Act (AMMA) doesn’t cover extracts, some of the most popular and medically efficacious products would have been taken from dispensary shelves and relegated to felony status.
Mr. Jones’ attorney summed it up appropriately, stating, “We are gratified that the Arizona Supreme Court has honored the intent of the electorate to make cannabis in any form available to AMMA-compliant patients.”